Sichuan Goldstone Asia Pharmaceutical Inc. / Fundamentals

    Income statement

    Net revenue
    €127.56M
    Cost of goods sold
    €54.26M
    Gross profit
    €73.30M
    SG&A expenses
    €16.38M
    R&D expenses
    €6.47M
    EBITDA
    €16.66M
    D&A
    €0.00
    EBIT
    €17.04M
    Interest expenses
    €152.60K
    EBT
    €16.51M
    Tax expenses
    €2.83M
    Net income
    €14.08M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €18.98M
    Changes in working capital
    €0.00
    Operating cash flow
    €18.98M
    Capex
    €11.32M
    Other investing cash flow
    €29.44K
    Net investing cash flow
    -€22.31M
    Total cash dividends paid
    -€3.43M
    Issuance of common stock
    €0.00
    Debt repayment
    -€4.76M
    Other financing cash flow
    €762.92K
    Net financing cash flow
    -€7.43M
    Foreign exchange effects
    €27.82K
    Net change in cash
    €17.26M
    Cash at end of period
    €48.51M
    Free cash flow
    €30.30M

    Balance sheet

    Cash and cash equivalents
    €48.51M
    Cash and short-term investments
    €51.51M
    Total receivables
    €31.17M
    Inventory
    €23.30M
    Other current assets
    €9.51M
    Total current assets
    €115.49M
    Property, plant & equipment
    €88.05M
    Goodwill
    €13.00M
    Intangible assets
    €23.25M
    Long-term investments
    €0.00
    Other non-current assets
    €114.27M
    Total non-current assets
    €240.44M
    Total assets
    €355.93M
    Accounts payable
    €11.13M
    Short-term debt
    €13.80M
    Other current liabilities
    €20.51M
    Total current liabilities
    €47.80M
    Long-term debt
    €1.82M
    Deferred tax liabilities
    €7.21M
    Other non-current liabilities
    €54.86K
    Total non-current liabilities
    €9.84M
    Total liabilities
    €57.63M
    Common stock
    €47.80M
    Retained earnings
    €26.80M
    Other equity
    €0.00
    Total equity
    €298.30M
    Total liabilities and shareholders' equity
    €355.93M

    Company information

    Market capitalization
    €459.84M
    Employees
    1.9K
    Enterprise Value
    €3.94B

    Company ratios

    Gross margin
    57.5%
    EBITDA margin
    13.1%
    EBIT margin
    13.4%
    EBT margin
    12.9%
    Net margin
    11.0%
    ROE
    4.7%
    ROA
    4.0%
    Asset turnover
    35.8%
    FCF margin
    6.0%
    FCF yield
    1.7%
    Efficiency ratio
    86.9%
    Net sales per employee
    €65.85K
    Net income per employee
    €7.27K

    Notifications